Dianne Angus
Follow
Get notifications in MyBN when activity occurs.
Dianne Angus
Non-Executive Chair / Argenica Therapeutics
Most Notable Role
Dianne Angus has executive managerial and company director experience in the biotechnology, biopharmaceutical, agritech and healthcare industries; including practical experience in innovation curation, asset development and commercialisation.
She also has over 18 years of experience in ASX- and NASDAQ-listed companies including Neuren Pharmaceuticals and Prana Biotechnology (now Alterity Therapeutics).
She also has over 18 years of experience in ASX- and NASDAQ-listed companies including Neuren Pharmaceuticals and Prana Biotechnology (now Alterity Therapeutics).
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1838th | Imagion Biosystems | -88% | -42% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Imagion Biosystems | $5.2m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEWS: Tagged in Board Moves December 1, 2023 | 01 Dec 2023 |
| NEW ROLE: Non-Executive Chair, Argenica Therapeutics | 01 Dec 2023 |
| NEW ROLE: Non-Executive Director, Cyclopharm | 01 Dec 2023 |
| NEW ROLE: Non-Executive Director, Neuren Pharmaceuticals | 03 Nov 2020 |
| NEW ROLE: Non-Executive Director, Imagion Biosystems | 03 Nov 2020 |
